Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.
about
Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system.Localization and function of the cannabinoid CB1 receptor in the anterolateral bed nucleus of the stria terminalisCannabis and psychiatric disorders: it is not only addictionThe endocannabinoid system as a target for the treatment of cannabis dependenceThe endocannabinoid system as an emerging target of pharmacotherapyExposure to a Highly Caloric Palatable Diet During Pregestational and Gestational Periods Affects Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Adiposity and Anxiety-Like Behaviors in Male Rat Offspring.The role of CB1 receptors in psychostimulant addictionNicotine-induced anxiety-like behavior in a rat model of the novelty-seeking phenotype is associated with long-lasting neuropeptidergic and neuroplastic adaptations in the amygdala: effects of the cannabinoid receptor 1 antagonist AM251Endocannabinoid-mediated synaptic plasticity and addiction-related behaviorDifferential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats.Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects.Pursuing paradoxical proconvulsant prophylaxis for epileptogenesisDeficiency in endocannabinoid signaling in the nucleus accumbens induced by chronic unpredictable stress.Short-term adaptation of conditioned fear responses through endocannabinoid signaling in the central amygdalaEffects of intra-amygdala infusion of CB1 receptor agonists on the reconsolidation of fear-potentiated startle.Input-dependent synaptic targeting of alpha(2)-subunit-containing GABA(A) receptors in synapses of hippocampal pyramidal cells of the rat.Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142.Interaction Between the Cannabinoid and Vanilloid Systems on Anxiety in Male Rats.Circuits controlling energy balance and mood: inherently intertwined or just complicated intersections?The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice.A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.Rimonabant: From RIO to Ban.Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.Regulation of the hypothalamic-pituitary-adrenal axis circadian rhythm by endocannabinoids is sexually diergic.Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient miceThe endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.Ghrelin-induced orexigenic effect in rats depends on the metabolic status and is counteracted by peripheral CB1 receptor antagonism.Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus.The psychiatric side-effects of rimonabant.Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in ratsChronic unpredictable stress enhances cocaine-conditioned place preference in type 1 cannabinoid receptor knockout mice.Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors.Divergent effects of genetic variation in endocannabinoid signaling on human threat- and reward-related brain functionThe utility of animal models to evaluate novel anti-obesity agents.Correlated species differences in the effects of cannabinoid ligands on anxiety and on GABAergic and glutamatergic synaptic transmission.Serum contents of endocannabinoids are correlated with blood pressure in depressed women.Repeated cannabinoid administration increases indices of noradrenergic activity in ratsThe endocannabinoid system: physiology and pharmacology.Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.Study the Effect of Endocannabinoid System on Rat Behavior in Elevated Plus-Maze
P2860
Q21132308-A0A6B8A5-3016-4B09-AE53-A49AF79E726EQ21142667-F15CB3CD-8FDE-414F-9F0A-9B0D9AB0508CQ22242611-BB55132C-FA5B-4C96-A66E-24FEE32F34A0Q24648135-FE42606E-F9FA-462B-BBEF-F40ED81054C7Q24648473-523F9A84-0C62-43FF-B74B-E03037DBE841Q27321798-9F84002E-101F-4D31-A2B4-8B22BFAA2BCBQ28280265-595DB526-BA2B-45AF-BC30-B052C1DE8C61Q28564481-30F8322A-F766-42EA-A5F9-DFC4711DA7D6Q29042501-EBF013AF-ABC8-48D3-BB2B-1C5810A2B436Q30437947-96DD09EB-106A-4D23-89F5-F1F89397AFCCQ30473707-B1054D05-8BDC-4457-8B63-260882DF9485Q30495206-D66CB985-AE65-4A75-8589-165BA17BE081Q30498533-4A80005A-AF0E-4676-B1B8-899CDD6FA298Q30498563-CE1E3A57-10BD-46B1-8825-7EB3881DE248Q30498998-47F19326-5A53-43A1-9921-619E121F71ABQ31900249-03E14E10-0E0A-43AB-93A2-95AB65E3A68BQ33635704-E3610754-18B8-4E5B-95F7-FD83E010E01BQ33716706-CBA1BFB9-D73E-47CD-B4ED-5F4EF422F24AQ33717463-B19B5ABC-F6E2-4D63-9E24-998EC390F36BQ33822403-27840E9A-2FE8-42BB-81CE-776F24854694Q33839407-8D4878A2-A525-4E40-91D9-1B8C9FBF2D5EQ34202105-E22885F3-655B-4F09-92F3-E8E5C81BA18EQ34234907-7AF9142E-8D58-4C74-B82B-32C22F1FFA41Q34244358-1F949F5D-DCAC-47EB-9862-7B367F101D45Q34608846-09653833-8DB7-4844-AD60-6CA35F2CFDABQ34626755-0E1C75A7-8010-4AEA-8F0C-E8A02DC3E2DAQ34658658-DC67AD10-4B81-43FD-9CA9-32180627DDD6Q34660430-EC4E80D7-D221-4432-BFC8-B9F8D3A4B161Q34990771-B3BD22F3-5F19-40CD-A219-6E6DCF93101CQ35119719-9139E6D0-CC34-4D33-B3EE-676D81F5FE3EQ35219200-FBB5FECB-90BD-448F-B966-699F9F1D2CB0Q35532072-82FA9506-A836-4423-8FC4-52A6CB91D1E8Q35548447-3733BAE0-DE57-4A37-9222-651CA03195D2Q35589958-28084DEA-58BC-481E-8EEC-D086CBF7ED46Q35839753-130FE628-C93E-4DE3-969E-9FCF8719E292Q35907965-148424ED-ED4B-4282-A073-A2351CE598B2Q35928133-73FAB5CE-D909-4B67-A2E7-282F4737F196Q35954057-63B75D01-071F-4618-81A4-9B5217DAE91EQ36184363-B3D04E27-CE10-4BB5-95AA-45A323CD2CE4Q36310074-73640EBA-1A08-4B15-9AA7-621746623B18
P2860
Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Acute administration of the CB ...... ety-like responses in the rat.
@en
Acute administration of the CB ...... ety-like responses in the rat.
@nl
type
label
Acute administration of the CB ...... ety-like responses in the rat.
@en
Acute administration of the CB ...... ety-like responses in the rat.
@nl
prefLabel
Acute administration of the CB ...... ety-like responses in the rat.
@en
Acute administration of the CB ...... ety-like responses in the rat.
@nl
P2093
P921
P1433
P1476
Acute administration of the CB ...... ety-like responses in the rat.
@en
P2093
E Hernández
F Rodríguez de Fonseca
I del Arco
M A Villanúa
M R Carrera
P304
P356
10.1097/00001756-199701200-00023
P577
1997-01-01T00:00:00Z